MDGL Competitors & Alternatives
Compare Madrigal Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
MDGL
Main Stock$499.71
Tradestie Score
53
Market Cap
$10.01B
Revenue Growth
0.7%
Analyst Upside
+36.5%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$227.31
|
$12.36B | 17.9 | 69 | Compare |
|
EXEL
Exelixis Inc
|
$57.94
|
$11.09B | 18.4 | 48 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$35.50
|
$10.76B | - | 50 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$188.94
|
$10.74B | - | 36 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$58.44
|
$10.53B | 162.2 | 59 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$44.00
|
$10.49B | - | 68 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$66.91
|
$10.22B | - | 73 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.40
|
$9.33B | 62.5 | 57 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$114.03
|
$8.88B | 256.1 | 49 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$106.94
|
$8.77B | 32.4 | 52 | Compare |
More MDGL Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry